45 research outputs found
Monocytes Expose Factor XIII-A and Stabilize Thrombi against Fibrinolytic Degradation
Acknowledgments: We acknowledge the University of Aberdeen Microscopy and Histology Facility and the Iain Fraser Cytometry for use of facilities and advice. Funding: The work presented here was funded the University of Aberdeen Development Trust and by project grants from Friend of Anchor (RS2015 006), the British Heart Foundation (PG/15/82/31721), Royal Embassy of Saudi Arabia Cultural Bureau (KFMCS74) and a British Heart Foundation Fellowship (FS/11/2/28579) awarded to N.J.M.Peer reviewedPublisher PD
Complex magnetic ordering behavior in the frustrated perovskite Ba2MnMoO6
New and exotic ground states of magnetic materials are highly sought after and are extensively studied for the insights they provide into the thermodynamics of disorder and fundamental magnetic interactions. By controlling the crystal structure of an appropriate magnetic lattice, it is possible to cause the strong magnetic exchange interactions to sum to zero and so be frustrated. Due to the presence of this frustration, the lowest energy configuration that results may be crucially dependent on the tiniest of energy differences between a multitude of states that have (almost) the same energy. The keen interest in these materials arises from the fact that these finely balanced systems offer a way of probing classical or quantum mechanical interactions that are of fundamental importance but are too weak to be observed in non-frustrated systems. Here, we combine local and crystallographic probes of the cation-ordered double perovskite Ba2MnMoO6 that contains a face-centered cubic lattice of S = 5/2 Mn2+ cations. Neutron diffraction measurements below 9.27(7) K indicate that a fourfold degenerate non-collinear antiferromagnetic state exists with almost complete ordering of the Mn2+ spins. Muon spin relaxation measurements provide a local probe of the magnetic fields inside this material over the t1/2 = 2.2 µs lifetime of a muon, indicating a slightly lower Néel transition temperature of 7.9(1) K. The dc susceptibility data do not show the loss of magnetization that should accompany the onset of the antiferromagnetic order; they indicate that a strongly antiferromagnetically coupled paramagnetic state [θ = −73(3) K] persists down to 4 K, at which temperature a weak transition occurs. The behavior of this material differs considerably from the closely related compositions Ba2MnMO6 (M = W, Te), which show collinear ordering arrangements and well defined antiferromagnetic transitions in the bulk susceptibility. This suggests that the Mo6+ cation leads to a fine balance between the nearest and next-nearest neighbor superexchange in these frustrated double perovskite structures
RESEARCH Open Access
Involving consumers and the community in the development of a diagnostic instrument for fetal alcohol spectrum disorders in Australi
A standardised protocol for assessment of relative SARS-CoV-2 variant severity, with application to severity risk for COVID-19 cases infected with Omicron BA.1 compared to Delta variants in six European countries
Several SARS-CoV-2 variants that evolved during the COVID-19 pandemic have
appeared to differ in severity, based on analyses of single-country datasets.
With decreased SARS-CoV-2 testing and sequencing, international collaborative
studies will become increasingly important for timely assessment of the
severity of newly emerged variants. The Joint WHO Regional Office for Europe
and ECDC Infection Severity Working Group was formed to produce and pilot a
standardised study protocol to estimate relative variant case-severity in
settings with individual-level SARS-CoV-2 testing and COVID-19 outcome data
during periods when two variants were co-circulating. To assess feasibility,
the study protocol and its associated statistical analysis code was applied by
local investigators in Denmark, England, Luxembourg, Norway, Portugal and
Scotland to assess the case-severity of Omicron BA.1 relative to Delta cases.
After pooling estimates using meta-analysis methods (random effects estimates),
the risk of hospital admission (adjusted hazard ratio [aHR]=0.41, 95% CI
0.31-0.54), ICU admission (aHR=0.12, 95% CI 0.05-0.27), and death (aHR=0.31,
95% CI 0.28-0.35) was lower for Omicron BA.1 compared to Delta cases. The aHRs
varied by age group and vaccination status. In conclusion, this study has
demonstrated the feasibility of conducting variant severity analyses in a
multinational collaborative framework. The results add further evidence for the
reduced severity of the Omicron BA.1 variant.Comment: 21 pages, 6 figures (excluding supplementary material
A modified Delphi study of screening for fetal alcohol spectrum disorders in Australia
Background: There is little reliable information on the prevalence of fetal alcohol spectrum disorders (FASD) in Australia and no coordinated national approach to facilitate case detection. The aim of this study was to identify health professionals’ perceptions about screening for FASD in Australia. Method: A modified Delphi process was used to assess perceptions of the need for, and the process of, screening for FASD in Australia. We recruited a panel of 130 Australian health professionals with experience or expertise in FASD screening or diagnosis. A systematic review of the literature was used to develop Likert statements on screening coverage, components and assessment methods which were administered using an online survey over two survey rounds. Results: Of the panel members surveyed, 95 (73%) responded to the questions on screening in the first survey round and, of these, 81 (85%) responded to the second round. Following two rounds there was consensus agreement on the need for targeted screening at birth (76%) and in childhood (84%). Participants did not reach consensus agreement on the need for universal screening at birth (55%) or in childhood (40%). Support for targeted screening was linked to perceived constraints on service provision and the need to examine the performance, costs and benefits of screening. For targeted screening of high risk groups, we found highest agreement for siblings of known cases of FASD (96%) and children of mothers attending alcohol treatment services (93%). Participants agreed that screening for FASD primarily requires assessment of prenatal alcohol exposure at birth (86%) and in childhood (88%), and that a checklist is needed to identify the components of screening and criteria for referral at birth (84%) and in childhood (90%). Conclusions: There is an agreed need for targeted but not universal screening for FASD in Australia, and sufficient consensus among health professionals to warrant development and evaluation of standardised methods for targeted screening and referral in the Australian context. Participants emphasised the need for locally-appropriate, evidence-based approaches to facilitate case detection, and the importance of ensuring that screening and referral programs are supported by adequate diagnostic and management capacity
Fetal alcohol spectrum disorder: development of concensus referral criteria for specialist diagnostic assessment in Australia
Background: Fetal alcohol spectrum disorder (FASD) is known to be under-recognised in Australia. The use of standard methods to identify when to refer individuals who may have FASD for specialist assessment could help improve the identification of this disorder. The purpose of this study was to develop referral criteria for use in Australia. Method: An online survey about FASD screening and diagnosis in Australia, which included 23 statements describing criteria for referral for fetal alcohol syndrome (FAS) and FASD based on published recommendations for referral in North America, was sent to 139 health professionals who had expertise or involvement in FASD screening or diagnosis. Survey findings and published criteria for referral were subsequently reviewed by a panel of 14 investigators at a consensus development workshop where criteria for referral were developed.Results: Among the 139 health professionals who were sent the survey, 103 (74%) responded, and 90 (65%) responded to the statements on criteria for referral. Over 80% of respondents agreed that referral for specialist evaluation should occur when there is evidence of significant prenatal alcohol exposure, defined as 7 or more standard drinks per week and at least 3 standard drinks on any one day, and more than 70% agreed with 13 of the16 statements that described criteria for referral other than prenatal alcohol exposure. Workshop participants recommended five independent criteria for referral: confirmed significant prenatal alcohol exposure; microcephaly and confirmed prenatal alcohol exposure; 2 or more significant central nervous system (CNS) abnormalities and confirmed prenatal alcohol exposure; 3 characteristic FAS facial anomalies; and 1 characteristic FAS facial anomaly, growth deficit and 1 or more CNS abnormalities .Conclusion: Referral criteria recommended for use in Australia are similar to those recommended in North America. There is a need to develop resources to raise awareness of these criteria among health professionals and evaluate their feasibility, acceptability and capacity to improve the identification of FASD in Australia
Midwives' knowledge, attitudes and practice about alcohol exposure and the risk of fetal alcohol spectrum disorder
Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples
Funder: NCI U24CA211006Abstract: The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus somatic mutation calls using whole exome sequencing (WES) and whole genome sequencing (WGS), respectively. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2,658 cancers across 38 tumour types, we compare WES and WGS side-by-side from 746 TCGA samples, finding that ~80% of mutations overlap in covered exonic regions. We estimate that low variant allele fraction (VAF < 15%) and clonal heterogeneity contribute up to 68% of private WGS mutations and 71% of private WES mutations. We observe that ~30% of private WGS mutations trace to mutations identified by a single variant caller in WES consensus efforts. WGS captures both ~50% more variation in exonic regions and un-observed mutations in loci with variable GC-content. Together, our analysis highlights technological divergences between two reproducible somatic variant detection efforts